Technical Aspects of Laparoscopic Distal Pancreatectomy for Benign and Malignant Disease: Review of the Literature
Executive Summary
Distal pancreatectomy (DP) serves as the standard curative treatment for lesions in the pancreatic body and tail, ranging from symptomatic benign tumors to malignant disease. While traditionally performed through open surgery, the laparoscopic approach (LDP) has gained significant traction. The primary clinical advantages of LDP include accelerated postoperative recovery, reduced hospital stays, and improved rates of spleen preservation.
However, the procedure remains technically demanding, particularly regarding oncological efficacy for malignancies and the management of postoperative pancreatic fistula (POPF), which remains the most frequent complication. While several technical interventions—such as mesh reinforcement of the staple line and the administration of the somatostatin analogue pasireotide—have shown promise in reducing POPF in randomized controlled trials, no single strategy has yet been confirmed across multiple consecutive studies. This briefing synthesizes current literature on surgical techniques, spleen preservation strategies, and fistula prevention.
1. Clinical Indications and Approach
Distal pancreatectomy involves the resection of pancreatic tissue to the left of the portomesenteric vein. The indications for surgery depend on the nature of the lesion:
Benign Neoplasms: Surgery is indicated only in cases of incapacitating symptoms.
Premalignant Neoplasms: Resection is required to prevent progression to cancer.
Malignant Neoplasms: Surgery remains the only potential curative therapy.
Laparoscopic vs. Open Surgery
LDP is increasingly considered the standard for benign and premalignant disease. Meta-analyses of cohort and case-matched studies indicate that LDP offers:
Earlier postoperative recovery.
Reduced length of hospital stay.
Potentially higher rates of spleen preservation (odds ratio of 3 compared to open surgery).
Conversion rates from laparoscopic to open surgery range from 0% to 33%. Common reasons for conversion include severe bleeding, extensive tumor growth, and lack of progress. Conversion is viewed as a measure of patient safety rather than a complication.
2. Technical Execution of Laparoscopic Distal Pancreatectomy
Trocar Placement and Exposure
The procedure typically utilizes four to five trocars placed in a semicircular fashion around an umbilical camera.
Access: The gastrocolic ligament is opened while preserving gastroepiploic vessels.
Retraction: The stomach is lifted using sutures or a laparoscopic retractor to expose the pancreas.
Ultrasound: Intraoperative ultrasound is used to define the lesion's location and its relationship to splenic vessels.
Mobilization and Transection
Surgeons often prefer a medial-to-lateral approach. The pancreas is mobilized by lifting the inferior border, and a nylon tape is used to delineate surgical planes. The pancreas is typically transected first, followed by the separation of the splenic vessels.
3. Spleen Preservation Strategies
In non-malignant cases, preserving the spleen is critical to avoid the need for lifelong vaccinations and the risk of potentially lethal postsplenectomy sepsis. Two primary techniques are employed:
A splenectomy must be performed if the surgeon observes signs of extensive splenic ischemia at the end of the procedure, which occurs in approximately 10% of cases.
4. Laparoscopic Management of Pancreatic Cancer
For malignancy, the Radical Antegrade Modular Pancreatosplenectomy (RAMPS) is the preferred approach. It aims to achieve superior radical resection margins and comprehensive lymphadenectomy.
RAMPS Variations
Anterior RAMPS: Includes resection of Gerota's fascia; used when the adrenal gland is not involved.
Posterior RAMPS: Includes resection of involved organs, such as the left adrenal gland or kidney.
Lymphadenectomy Standards
According to the International Study Group on Pancreatic Surgery (ISGPS), the following lymph node stations are critical:
Mandatory: Stations 10 (splenic hilum), 11 (splenic artery), and 18 (inferior border).
Optional/Recommended: Stations 8a (common hepatic artery) and 9 (celiac trunk), particularly for tumors located in the pancreatic body.
Yonsei Criteria for LDP in Cancer
To ensure safety, candidates for a laparoscopic approach to cancer should ideally meet the Yonsei criteria:
Tumor confined to the pancreas.
Tumor located 1–2 cm from the celiac trunk.
Intact fascial layer between the pancreas and the left adrenal gland/kidney.
5. Postoperative Pancreatic Fistula (POPF)
POPF remains the most frequent complication, with incidence rates ranging from 4% to 69%. LDP has not significantly reduced the rate of POPF compared to open surgery.
Definition and Impact
The International Study Group on Pancreatic Fistula (ISGPF) defines POPF as drain output on or after postoperative day 3 with an amylase level greater than three times the upper normal serum level. POPF can lead to:
Intra-abdominal abscesses and sepsis.
Postpancreatectomy hemorrhage.
Delayed gastric emptying and ileus.
Prevention Strategies and Evidence
Surgeons have explored various techniques to secure the pancreatic remnant, with varying levels of success:
Transection Techniques: Stapler closure is common in LDP. Evidence suggests it is comparable to hand-sewn closure. The use of 2.5 mm vascular staple cartridges and a "slow closing" technique (2–3 minutes) may reduce fistula rates.
Reinforcement: Randomized controlled trials have shown that mesh reinforcement of the staple line can significantly reduce POPF (e.g., from 20% to 1% in one study).
Pharmacological Intervention: The administration of pasireotide (a long-acting somatostatin analogue) has been shown to significantly reduce the risk of clinically relevant POPF. Prophylactic stenting, however, has not been effective and may increase abscess formation.
Glues and Patches: The use of fibrin glue, sealant patches (e.g., TachoSil), and falciform ligament patches has generally not shown a significant reduction in POPF in randomized trials.
6. Conclusion
Laparoscopic distal pancreatectomy offers clear advantages in terms of patient recovery and hospital efficiency. While it is highly effective for benign disease, its application in malignancy requires strict adherence to oncological principles like the RAMPS procedure. Despite advancements in surgical tools and techniques, POPF remains a primary challenge. Current evidence highlights mesh reinforcement and pasireotide as the most promising interventions for reducing fistula rates, though further multicenter randomized research is required to standardize these technical aspects.
